0001933414-24-000018.txt : 20240523
0001933414-24-000018.hdr.sgml : 20240523
20240523162051
ACCESSION NUMBER: 0001933414-24-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240522
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Litzka Olivier
CENTRAL INDEX KEY: 0001963940
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41614
FILM NUMBER: 24978569
MAIL ADDRESS:
STREET 1: C/O MINERALYS THERAPEUTICS, INC.
STREET 2: 150 N. RADNOR CHESTER RD, STE. F200
CITY: RADNOR
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mineralys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001933414
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 N. RADNOR CHESTER ROAD
STREET 2: SUITE F200
CITY: RADNOR
STATE: PA
ZIP: 19087
BUSINESS PHONE: (888) 378-6240
MAIL ADDRESS:
STREET 1: 150 N. RADNOR CHESTER ROAD
STREET 2: SUITE F200
CITY: RADNOR
STATE: PA
ZIP: 19087
4
1
wk-form4_1716495632.xml
FORM 4
X0508
4
2024-05-22
0
0001933414
Mineralys Therapeutics, Inc.
MLYS
0001963940
Litzka Olivier
150 N. RADNOR CHESTER ROAD
SUITE F200
RADNOR
PA
19087
1
0
0
0
0
Stock Option
12.52
2024-05-22
4
A
0
22000
0
A
2034-05-22
Common Stock
22000
22000
D
The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting.
/s/ Adam Levy, Attorney-in-fact
2024-05-23